|
David A.H. Lee, M.D., Ph.D. has served as Executive Vice President, Research & Development and Chief Scientific Officer since April 2004 and was previously Senior Vice President, Research & Development and Regulatory Affairs since December 1997. Prior to joining Endo, Dr. Lee was Executive Vice President, Research and Development for CoCensys, Inc., an emerging pharmaceuticals company based in Irvine, California, from 1992 through 1997. Prior to joining CoCensys, he held various positions at Solvay Pharmaceuticals in the Netherlands, ranging from head of global clinical development programs to his final position as V.P. Research & Development. Dr. Lee received his M.D. and Ph.D. degrees from the University of London and specialized in internal medicine and gastroenterology prior to joining the pharmaceutical industry. | 